Evidence map›Paper›PMID 39363860›Full record

ArticleHaematologica2025

Adverse clinical outcomes associated with sickle cell trait at high altitude.

Katherine A Stafford, Soravis Osataphan, Rushad Patell, Nigel S Key

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katherine A StaffordDenver Health and Hospital Authority, Hospital Medicine, Denver, CO, USA; University of Colorado Anschutz Medical Campus, Department of Medicine, Aurora, CO. Katherine.stafford@cuanschutz.edu.
Soravis OsataphanBeth Israel Deaconess Medical Center, Division of Hematology and Oncology, Boston, MA.
Rushad PatellBeth Israel Deaconess Medical Center, Division of Hematology and Oncology, Boston, MA.
Nigel S KeyThe University of North Carolina at Chapel Hill School of Medicine, Blood Research Center and Division of Hematology, Chapel Hill, NC.

Funding

Mechanism of sickle cell disease-specific venous thromboembolismR01HL157441 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KEY, NIGEL S., PAWLINSKI, RAFAL L · 2021 to 2024
$2.6M
Mechanisms of venous thrombosis and renal dysfunction in sickle traitR01HL171501 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Nigel S. Key, RAFAL L PAWLINSKI · 2024 to 2026
$2.1M
NHLBI NIH HHS R01 HL157441NHLBI NIH HHS R01 HL171501
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39363860
PMCPMC11788638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.